Biostatistics Services Case Studies
IDMC support for a study assessing a novel therapeutic for severe COVID-19.
Functional service provision to support a vaccine clinical trial.
Generating a statistical evidence package to support orphan drug designation.
Biostatistics support for an early phase oncology clinical trial.
Biostatistics Services Case Studies
IDMC support for a study assessing a novel therapeutic for severe COVID-19.
Functional service provision to support a vaccine clinical trial.
Generating a statistical evidence package to support orphan drug designation.
Biostatistics support for an early phase oncology clinical trial.
Biostatistics Services Case Studies
IDMC support for a study assessing a novel therapeutic for severe COVID-19.
Functional service provision to support a vaccine clinical trial.
Generating a statistical evidence package to support orphan drug designation.
Biostatistics support for an early phase oncology clinical trial.
Statistical Consulting Services Case Studies
Generating synthetic control arms to repurpose treatments for patients with severe COVID-19.
Creating Go/No Go decision-making criteria for early-stage studies.
Building and validating a composite biomarker model to predict emphysema progression.
Simulating patient level outcome data to inform clinical trial design based on real-world, clinical trial and literature data.
Identifying the best overall strategy for study designs and drug development pathways.
Bayesian Extrapolation to Evaluate Efficacy in Pediatric Subjects using Adult Data.
Enabling early approval with a smarter approach to generating robust clinical evidence.
Statistical Consulting Services Case Studies
Generating synthetic control arms to repurpose treatments for patients with severe COVID-19.
Creating Go/No Go decision-making criteria for early-stage studies.
Building and validating a composite biomarker model to predict emphysema progression.
Simulating patient level outcome data to inform clinical trial design based on real-world, clinical trial and literature data.
Identifying the best overall strategy for study designs and drug development pathways.
Bayesian Extrapolation to Evaluate Efficacy in Pediatric Subjects using Adult Data.
Enabling early approval with a smarter approach to generating robust clinical evidence.
Statistical Consulting Services Case Studies
Generating synthetic control arms to repurpose treatments for patients with severe COVID-19.
Creating Go/No Go decision-making criteria for early-stage studies.
Building and validating a composite biomarker model to predict emphysema progression.
Simulating patient level outcome data to inform clinical trial design based on real-world, clinical trial and literature data.
Identifying the best overall strategy for study designs and drug development pathways.
Bayesian Extrapolation to Evaluate Efficacy in Pediatric Subjects using Adult Data.
Enabling early approval with a smarter approach to generating robust clinical evidence.
Data Science Services Case Studies
Identifying disease areas and endpoints that best demonstrate treatment efficacy.
Constructing a synthetic control arm for a study with a small population.
Data Science Services Case Studies
Identifying disease areas and endpoints that best demonstrate treatment efficacy.
Constructing a synthetic control arm for a study with a small population.
Data Science Services Case Studies
Identifying disease areas and endpoints that best demonstrate treatment efficacy.
Constructing a synthetic control arm for a study with a small population.
KerusCloud Use Case Examples
Identifying an adaptive trial design to maximise success with a smaller sample size.
Adapting to new information to identify a hidden risk, the impact of correlations.
KerusCloud Use Case Examples
Identifying an adaptive trial design to maximise success with a smaller sample size.
Adapting to new information to identify a hidden risk, the impact of correlations.
KerusCloud Use Case Examples
Identifying an adaptive trial design to maximise success with a smaller sample size.
Adapting to new information to identify a hidden risk, the impact of correlations.